NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the target of a large drop in short interest in January. As of January 31st, there was short interest totalling 81,600 shares, a drop of 77.9% from the January 15th total of 369,700 shares. Based on an average daily volume of 263,400 shares, the short-interest ratio is currently 0.3 days.

NovaBay Pharmaceuticals Price Performance

Shares of NBY stock remained flat at $0.65 during mid-day trading on Wednesday. 58,185 shares of the stock were exchanged, compared to its average volume of 379,507. The firm has a market capitalization of $2.74 million, a P/E ratio of -0.07 and a beta of 2.82. NovaBay Pharmaceuticals has a twelve month low of $0.36 and a twelve month high of $9.08.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.